Evidence map›Paper›PMID 39403115›Full record

ArticleTherapeutic advances in neurological disorders2024

Optimizing outcomes in drug-resistant mesial temporal lobe epilepsy patients undergoing stereoelectroencephalography-guided radiofrequency thermocoagulation.

Stéphane Jean, Rifeng Jiang, Yihai Dai, Weitao Chen, Weihong Liu, Donghuo Deng, Panashe Tevin Tagu, Xiaoqiang Wei, Shan Chen, Xinrong Fang and 1 more

Abstract read
In one paragraph

Article in Therapeutic advances in neurological disorders, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Stéphane JeanPediatric Epilepsy Center, Fujian Medical University Fuzhou Children's Hospital, Fuzhou, China.ORCID https://orcid.org/0009-0009-4859-0189
Rifeng JiangDepartment of Radiology, Fujian Medical University Union Hospital, Fuzhou, China.
Yihai DaiDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China.
Weitao ChenPediatric Epilepsy Center, Fujian Medical University Fuzhou Children's Hospital, Fuzhou, China.
Weihong LiuPediatric Epilepsy Center, Fujian Medical University Fuzhou Children's Hospital, Fuzhou, China.
Donghuo DengFujian Medical University Union Hospital, Fuzhou, China.
Panashe Tevin TaguFujian Medical University Union Hospital, Fuzhou, China.
Xiaoqiang WeiDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China.
Shan ChenPediatric Epilepsy Center, Fujian Medical University Fuzhou Children's Hospital, Fuzhou, China.
Xinrong FangDepartment of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China.
Shiwei SongDepartment of Neurosurgery, Fujian Medical University Union Hospital, No. 29, Xinquan Road, 350001 Fuzhou, China.ORCID https://orcid.org/0000-0002-6105-8914

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mesial temporal lobe epilepsy (MTLE) epileptiform discharges have been reported to arise from the hippocampus or the extrahippocampal medial temporal cortex, such as the amygdala, and then propagate to the temporal lobe cortex. The surgical ablation of which of these structures would result in a better postoperative outcome is debatable. Objective: To assess the possible factors that might have influenced the postoperative outcome of a group of drug-resistant mesial MTLE patients who underwent stereoelectroencephalography (SEEG)-guided radiofrequency thermocoagulation (RFTC). Design: Single-center, retrospective. Methods: The present study utilized a pre- and postoperative gray matter voxel-by-voxel ablation mapping comparison approach, along with a white matter mapping of longitudinal changes in the native space technique, to evaluate the association between the post-SEEG implantation signal recordings (obtained from clinically relevant electrode contacts used during RFTC) and the post-RFTC ablation volume of the different selected regions of interest (ROIs). Results: The study included 22 patients (12 men and 10 women, mean age 28.86 ± 14.04 years). Sixteen patients (72.72%) were seizure-free (SF), and six patients (27.27%) were non-SF. Five patients (22.72%) experienced mild side effects following RFTC. The post-RFTC follow-up period varied from 12 to 48 months, with an average of 24.17 ± 9.86 months. The SF group was associated with a higher number of implanted electrode contacts in the amygdala that were used during RFTC, a larger preoperative volume of the amygdala; a larger ablation volume of both the amygdala and rhinal cortex. The ablation volume of the white matter was statistically similar between both groups. Conclusion: This study provides valuable insights into the significance of the amygdala and rhinal cortex as ROIs in the preoperative evaluation of patients with MTLE. Future implantation scheme plans should consider evaluating the preoperative volume of these ROIs. Additionally, increasing the number of electrode contacts implanted within these regions might be beneficial to capture more clinically relevant signals and enhance their ablation volume.

Indexed as

amygdalagray matterMTLERFTCrhinal cortexSEEGwhite matter

Identifiers

PMID39403115
PMCPMC11472416

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.